Predictions
Alphabet Inc. A
Start price
Target price
Perf. (%)
€121.80
07.09.21
07.09.21
€140.00
31.12.23
31.12.23
-21.44%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Alphabet Inc. A
Start price
Target price
Perf. (%)
€121.80
07.09.21
07.09.21
€140.00
31.12.23
31.12.23
-21.44%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Visa Inc. A
Start price
Target price
Perf. (%)
€192.18
07.09.21
07.09.21
€230.00
31.12.23
31.12.23
4.41%
02.09.22
02.09.22
Could be worthwhile Investment >10% per year
Visa Inc. A
Start price
Target price
Perf. (%)
€192.18
07.09.21
07.09.21
€230.00
31.12.23
31.12.23
4.41%
02.09.22
02.09.22
Could be worthwhile Investment >10% per year
Home Depot Inc.
Start price
Target price
Perf. (%)
€278.50
07.09.21
07.09.21
€350.00
31.12.23
31.12.23
-4.70%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Home Depot Inc.
Start price
Target price
Perf. (%)
€278.50
07.09.21
07.09.21
€350.00
31.12.23
31.12.23
-4.70%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€476.00
07.09.21
07.09.21
€550.00
31.12.23
31.12.23
4.08%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Ziopharm Oncology
Start price
Target price
Perf. (%)
€1.99
07.09.21
07.09.21
€4.00
31.12.23
31.12.23
52.84%
01.09.22
01.09.22
Could be worthwhile Investment >10% per year
RCI Hospitality Holdings Inc
Start price
Target price
Perf. (%)
€55.00
07.09.21
07.09.21
-
07.09.22
07.09.22
20.91%
08.09.22
08.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
EBIT growth >5% per year expected
Zscaler Inc
Start price
Target price
Perf. (%)
€244.20
06.09.21
06.09.21
-
06.09.22
06.09.22
-40.69%
07.09.22
07.09.22
Could be worthwhile Investment >10% per year
Innovative
Differentiated customer and product portfolio
Future proof or reliable business model
Zscaler Inc
Start price
Target price
Perf. (%)
€244.20
06.09.21
06.09.21
-
06.09.22
06.09.22
-40.69%
07.09.22
07.09.22
Could be worthwhile Investment >10% per year
Innovative
Differentiated customer and product portfolio
Future proof or reliable business model
Workday, Inc.
Start price
Target price
Perf. (%)
€234.30
06.09.21
06.09.21
-
06.09.22
06.09.22
-31.52%
07.09.22
07.09.22
Could be worthwhile Investment >10% per year
Growths faster than the competition
Future proof or reliable business model
Kroger Co.
Start price
Target price
Perf. (%)
€39.64
06.09.21
06.09.21
€60.00
06.09.22
06.09.22
23.37%
06.09.22
06.09.22
Could be worthwhile Investment >10% per year
Growths faster than the competition
Revenue growth >5% per year expected
Higher risks for its business
CrowdStrike Holdings Inc
Start price
Target price
Perf. (%)
€235.35
06.09.21
06.09.21
€300.00
31.07.23
31.07.23
-52.83%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€55.00
06.09.21
06.09.21
€120.00
31.12.23
31.12.23
-43.27%
10.09.21
10.09.21
Could be very worthwhile Investment >20% year
Greenidge Generation Holdings Inc.
Start price
Target price
Perf. (%)
€164.35
06.09.21
06.09.21
-
06.09.25
06.09.25
-93.95%
11.03.24
11.03.24
Probably not worthwhile Investment
Editas Medicine Inc
Start price
Target price
Perf. (%)
€58.60
05.09.21
05.09.21
€70.00
05.09.22
05.09.22
-8.43%
18.09.21
18.09.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good rating
Very low/no dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€212.55
05.09.21
05.09.21
€333.00
05.09.22
05.09.22
-85.70%
06.09.22
06.09.22
Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
ClearSign Combustion Corp.
Start price
Target price
Perf. (%)
€1.87
04.09.21
04.09.21
€0.000
04.09.22
04.09.22
2.14%
18.09.21
18.09.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€4.42
04.09.21
04.09.21
€2.00
04.09.22
04.09.22
-33.48%
18.09.21
18.09.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
Apple Inc.
Start price
Target price
Perf. (%)
€130.78
04.09.21
04.09.21
-
04.09.22
04.09.22
22.62%
10.08.22
10.08.22
Could be very worthwhile Investment >20% year
Apple Inc.
Start price
Target price
Perf. (%)
€130.78
04.09.21
04.09.21
-
04.09.22
04.09.22
22.62%
10.08.22
10.08.22
Could be very worthwhile Investment >20% year